Øget risiko for lipodystrofi er forbundet med individuelle faktorer, så som alderdom, og lægemiddelrelaterede faktorer som længere varighed af antiretroviral behandling og metaboliske forstyrrelser forbundet hermed.
A higher risk of lipodystrophy has been associated with individual factors such as older age, and with drug related factors such as longer duration of antiretroviral treatment and associated metabolic disturbances.